Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Completed · Phase 3 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

The primary objective of the study was to demonstrate the efficacy of Dupilumab administered concomitantly with topical corticosteroid (TCS) through Week 16 in adult participants with moderate-to-severe atopic dermatitis (AD) compared to placebo administered concomitantly with TCS.

Key facts

Study ID

NCT02260986

Run by

Regeneron Pharmaceuticals

People needed

740

Starts

2014-09-01

Expected to finish

2016-10-01

Last updated by the study team

2017-10-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Hot Springs, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Encinitas, California, United States
• Study site — Oceanside, California, United States
• Study site — Palmdale, California, United States
• Study site — San Diego, California, United States
• Study site — New Haven, Connecticut, United States
• Study site — Trumbull, Connecticut, United States
• Study site — Edgewater, Florida, United States
• Study site — Lake Worth, Florida, United States
• Study site — Miami Lakes, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Alpharetta, Georgia, United States
• Study site — Columbus, Georgia, United States
• Study site — Savannah, Georgia, United States
• Study site — West Dundee, Illinois, United States
• Study site — Carmel, Indiana, United States
• Study site — New Albany, Indiana, United States
• Study site — Rockville, Maryland, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Bay City, Michigan, United States
• Study site — Edina, Minnesota, United States
• Study site — Fridley, Minnesota, United States
• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.